The COVID-19 pandemic has brought numerous challenges to societies worldwide. Among those most vulnerable to the virus are our elderly population. As the pandemic continues to evolve, one crucial step in safeguarding the elderly has been the early rollout of vaccines.
Here, we will explore the importance of prioritising the elderly in vaccination efforts and the positive impact this strategy has had on their safety and well-being.
Stoneswood Care Home: Paving the Way for Happy & Healthy Residents
At Stoneswood Care Home, we care deeply about our residents and do everything we can to ensure an excellent quality of life. That’s why we recently had a chat with the BBC, discussing our plans to make vaccines available for residents earlier than usual.
There are a huge number of benefits to doing so, and the team here at Stoneswood are continuing to work with guidelines and healthcare professionals to ensure our residents remain safe and can continue to live healthy lives.
Why Elderly Residents Need Particular Attention
Higher Vulnerability
The elderly are at a significantly higher risk of severe illness and mortality if infected with COVID-19 or any other virus. Their immune systems may not respond as robustly, making it essential to protect them through vaccination.
Overwhelming Healthcare Systems
The surge in elderly patients with severe COVID-19, flu, or other virus symptoms can overwhelm healthcare systems, limiting the capacity to provide adequate care to all. Vaccinating the elderly early helps reduce the burden on hospitals and healthcare workers.
Isolation and Mental Health
Elderly individuals have been disproportionately affected by social isolation and loneliness during the pandemic due to safety precautions. Early vaccination can help them regain a sense of normalcy quicker, improving their mental health and overall well-being.
Why vaccines are effective in protecting the elderly
Stimulating an Immune Response
COVID-19 vaccines contain a small piece of the SARS-CoV-2 virus, often in the form of messenger RNA (mRNA) or viral vector. When a person is vaccinated, their immune system recognises these harmless viral components as foreign invaders and mounts an immune response. This response includes the production of antibodies and activation of immune cells, such as T cells.
Production of Antibodies
Antibodies are proteins that the immune system produces to target and neutralise the virus. The COVID-19 vaccines, including those based on mRNA technology like Pfizer-BioNTech and Moderna, stimulate the production of antibodies specific to the spike protein on the surface of the SARS-CoV-2 virus. These antibodies can neutralise the virus if the vaccinated person is exposed to it.
Memory Immune Response
After vaccination, the immune system “remembers” the spike protein and can rapidly respond if the person is exposed to the actual virus in the future. This memory response is critical for providing long-lasting protection.
Reducing Severity of Illness
While no vaccine is 100% effective, COVID-19 vaccines have demonstrated a high level of effectiveness in reducing the severity of illness, including severe disease, hospitalisation, and death. This is particularly important for older adults, who are more vulnerable to severe outcomes if they contract the virus.
Boosting Immune Function
COVID-19 vaccines can help boost the immune function of older adults, whose immune systems may weaken with age. This is especially significant because a robust immune response is necessary to combat the virus effectively.
Herd Immunity
By vaccinating a significant portion of the population, including the elderly, you can contribute to the development of herd immunity. Herd immunity occurs when a sufficient number of people in a community are immune to a disease, which makes it more challenging for the virus to spread. This indirectly protects vulnerable populations who may not respond as strongly to the vaccine.
Real-World Data
Real-world data and studies have shown that COVID-19 vaccines are highly effective at reducing COVID-19 cases, hospitalisations, and deaths among older adults. This evidence reinforces the safety and efficacy of these vaccines in this age group.
At Autograph Care, our residents’ health and quality of life is our priority. If you’d like to find out more about how we put our residents first here at Stoneswood, get in touch with the team today.
Adam Welsh
Adam joined Autograph Care shortly before the group purchased their first home, Inwood House, in 2019. Adam trained as a commercial lawyer, spending his early career working in London and overseas before relocating to the North West where he grew up. Whilst the role varies day-to-day, Adam is primarily responsible for supporting sales & marketing activity across the business and identifying other care homes to grow the Group.
